EPG Health’s Post

Empowering Innovation in Patient Care: Certified in Clinical Trials! I'm thrilled to announce that I've successfully completed the course on "An Overview on Clinical Trials" offered by PharmaState Academy. This comprehensive program equipped me with a foundational understanding of the clinical trial process, from meticulous design and ethical considerations to rigorous data analysis and real-world implications. Through a blend of interactive lectures and case studies, I gained valuable insights into the intricate steps involved in bringing new medications to market. I explored the significance of clinical trials in advancing medical research and improving patient care. This newfound knowledge empowers me to actively participate in discussions about clinical trial design, data interpretation, and the translation of research findings into effective therapeutic interventions #ClinicalTrials #PharmaceuticalResearch #PatientCare #DrugDevelopment

ClinicalTrials.gov is a website and online database of privately and publicly funded clinical research studies and information about their results from around the world. This service is maintained by the National Library of Medicine (NLM) at the National Institute of Health (NIH). Information on the website is submitted and updated by sponsors or investigators (The U.S. government does not review or approve the safety and science of the studies listed). The primary goal of ClinicalTrials.gov is to offer information about clinical research studies to the public, researchers, and healthcare professionals, supporting laws, regulations, and policies that require the public sharing of clinical trial information, including results. The Protocol Registration and Results System (PRS) is an application within clinicalTrials.gov used for submitting and managing clinical study information to the website. As part of the National Library of Medicine's (NLM) multi-year effort to modernize ClinicalTrials.gov, the classic version of the website will be retired in 3 days (on June 25, 2024). The modernized ClinicalTrials.gov will then become the primary platform to support future growth, enhance efficiency, and improve the user experience. NLM is also working on modernizing the Protocol Registration and Results System (PRS). The updated PRS (PRS Beta) will become the new primary registration site. This updated "Modernization Transition Top Questions" document provides current information, questions, and responses regarding the transition to the modernized ClinicalTrials.gov and PRS system. https://lnkd.in/e8yj56ie #NIH #NLM #PRS #ClinicalTrial #DrugDevelopment #RegulatoryAffairs #MedicalWriting #BioPharma

At Superior Clinical Research, our passion and dedication drive everything we do. Here’s why we care so deeply about clinical research and what motivates us to excel every day: Our Mission: We are committed to advancing medical science by conducting high-quality, ethical clinical trials. Our goal is to bring innovative treatments to market, improving patient outcomes and enhancing the quality of life for countless individuals. Our Values: Integrity: We uphold the highest standards of integrity in all our research activities, ensuring that every study is conducted with transparency and honesty. Diversity: We strive to increase diversity in clinical trials, recognizing the importance of including all communities in medical research. Community Trust: Building trust within our community is paramount. We engage with local populations, providing education and support to dispel myths and encourage participation in clinical research. Excellence: With over 25 years of collective experience, our team is dedicated to exceeding expectations in every trial we conduct. We utilize the latest technology to ensure precise and accurate results. Why We Do It: To Save Lives: Every trial we conduct brings us one step closer to new treatments and cures. We are driven by the knowledge that our work has the potential to save lives and make a profound impact on healthcare. To Foster Innovation: By partnering with leading pharmaceutical and biotech companies, we are at the forefront of medical innovation, helping to bring cutting-edge treatments to those who need them most. To Empower Patients: We believe in the power of informed and engaged patients. Through our trials, we provide patients with access to new treatments and the opportunity to contribute to medical advancements. At Superior Clinical Research, we are more than just researchers; we are advocates for better health and brighter futures. Join us in our mission to make a difference. Together, we can achieve remarkable advancements in medical science. #ClinicalResearch #MedicalInnovation #Healthcare #ResearchExcellence #PatientCare #SuperiorClinicalResearch

Yes, clinical trials and publications are important pieces of scientific communication, but when it comes to treatment adoption, their impact is less obvious. On the other hand, involvement in medical congresses triggers a domino sequence: Events kick off social conversations, creating a halo effect. The result is an amplification of scientific information and faster treatment adoption. Get the complete report for more insights: https://bit.ly/4dzdpsj Although the report findings prove that congress activity has a big impact, prioritizing and planning for congresses is time-intensive and not easy. I invite you to play with this interactive demo to see how Veeva Link Key People can help: https://bit.ly/3SVpuzZ

Clinical trials are powerful tools for innovation. They test medicines to see how well they work for different patients and answer key research questions needed to deliver new medicines.   Our aspiration at #BMSAustralia is that patients and researchers can experience the impact of scientific advancements and have the support to identify what’s right for them.    Our Study Connect portal is starting point for patients who are considering taking part in our clinical trials. Study Connect is developed to: 📌 Give patients, their caregivers and physicians a place to learn more about clinical trials and how they work 📌 Provide information on the conditions and current trials being conducted by #BMSAustralia 📌 Offer a pre-screen to help identify which clinical trials that a patient might qualify for 📌 Discover stories from people who have participated in clinical trials   Learn more here: https://lnkd.in/gdrGxiz

The goal: prove the value of your #medicalaffairs team's congress strategy The solution: recruit digitally motivated KOLs and foster high-quality discussion 🗣️ We know it's a challenge to get KOLs' attention during a congress event – but the best time to capture novel insight is in the moment. Within3 helped one #pharma team get relevant information as scientific disclosures were presented, so they could move on to next steps that much faster. 🔗 https://hubs.la/Q02ph4jn0

🚀 Just completed a course on Clinical Trials and Drug Development! 🚀 Key takeaways: Learned the critical phases of clinical trials and their role in advancing medicine. Discovered why people participate in trials and how it contribute to science. Explored the sponsor’s perspective and the journey from drug discovery to approval. Excited to apply this knowledge in the world of healthcare innovation! 🌟

Clinical research is witnessing a significant rise globally, driven by advancements in technology and collaboration between research institutions. Moreover, patient participation in clinical trials has grown, influenced by awareness and the potential for benefits from medical advancements. This trend underscores the evolving landscape of medical research, promising a future of innovative healthcare solutions. https://lnkd.in/gfR8FA-f

Only by putting an appropriate measurement in place can you be sure that your strategies and tactics are having the impact you need. Oxford PharmaGenesis connects the dots between innovative approaches to planning, choice of correct tactic, and measuring outcomes and impact. If you’re going to the upcoming 24th European Meeting of #ISMPP in London, drop by our website now to see how we can advise on #strategy and planning to create impact. #ExploreNewFrontiers #HealthScience #MedicalAffairs #MedicalEducation #ValueDemonstration #HEOR #PatientEngagement #MedicalCommunications #ISMPPEurope2024 https://lnkd.in/eRqQbFCE

MTRC shares the most relevant and impactful publications in the field of market access and HEOR for medical technologies in Europe through its Publications Digest. In a recent publication, Cangelosi et al. conducted a systematic review to assess how data from health technology assessments (HTAs) informs procurement decisions for medical devices. By synthesizing evidence from 11 relevant studies, the authors aimed to identify the criteria used in purchasing decisions, highlighting the minimal evidence of HTA influencing procurement. The authors emphasized the unmet need for enhanced transparency, incentivization for publishing procurement-related work, and further research to strengthen the connection between HTA and procurement, ultimately aiming to optimize resource allocation and expand access to innovative medical technologies within healthcare systems. https://lnkd.in/e-GEucZF